Samlyn Capital’s CVS Health CVS Stock Holding History

Samlyn Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-363,765	Closed	-$26.1M	–	83
2026 Q1	$26.1M	Sell	363,765 -856,808	-70%	-$66M	0.45%	57
2025 Q4	$96.9M	Buy	+1,220,573	New	+$96.2M	1.54%	18
2017 Q1	–	Sell	-646,403	Closed	-$51M	–	143
2016 Q4	$51M	Buy	646,403 +297,710	+85%	+$24.1M	1.16%	33
2016 Q3	$31M	Buy	+348,693	New	+$32.9M	0.74%	51
2015 Q4	–	Sell	-1,029,733	Closed	-$99.3M	–	83
2015 Q3	$99.3M	Sell	1,029,733 -56,900	-5%	-$5.98M	1.82%	20
2015 Q2	$114M	Buy	1,086,633 +378,333	+53%	+$38.7M	1.81%	19
2015 Q1	$73.1M	Buy	+708,300	New	+$71.7M	1.17%	34
2014 Q2	–	Sell	-289,011	Closed	-$21.6M	–	91
2014 Q1	$21.6M	Sell	289,011 -725,239	-72%	-$51.2M	0.5%	70
2013 Q4	$72.6M	Buy	+1,014,250	New	+$65.2M	1.82%	19

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Samlyn Capital's CVS Position: Q2 2026 in Review

Samlyn Capital sold out of CVS Health (CVS) in Q2 2026, closing a stake of 363,765 shares — an estimated $26.1M sold.

Samlyn Capital first reported a position in CVS in Q4 2013 and held it in 9 quarters. The position peaked at $114M in Q2 2015. 2,066 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Samlyn Capital reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Samlyn Capital sold 363,765 CVS Health shares in Q2 2026, an estimated $26.1M.
Samlyn Capital first reported a position in CVS Health in Q4 2013 and held it in 9 quarters.
Samlyn Capital's CVS Health position peaked at $114M in Q2 2015.
2,066 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.